In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their impact on cardiovascular outcomes. But do these pl
In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their impact on cardiovascular outcomes. But do these pleiotropic effects matter, or is ta all down to lipid lowering? At the University of Iowa,Jennifer Robinsonhas been trying to find out.
Tags
Related Episodes
Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
Ake Hjalmarson Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 AKE HJAL
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Judith Hochman Timothy Gardner Girish Mood Marc Cohen Late Opening of Total Occlusion: No Benefit from PCI for Patients with STEMI REFERENCE: LBCT II News Conference November 14th 2006 JUDITH HOCHMAN,
Audio Journal of Cardiovascular Medicine: September 7th 2006
Gilles Montalescot Freek Verheugt Angioplasty: Four-Continent RIVIERA Study Identifies “Real World” Modifiable Factors Which Affect Outcome REFERENCE: Abstract 3413, “Hot Line II&rdq